KR910011245A - Scopolamine transdermal absorption patch for preventing motion sickness, nausea and vomiting - Google Patents

Scopolamine transdermal absorption patch for preventing motion sickness, nausea and vomiting Download PDF

Info

Publication number
KR910011245A
KR910011245A KR1019890018473A KR890018473A KR910011245A KR 910011245 A KR910011245 A KR 910011245A KR 1019890018473 A KR1019890018473 A KR 1019890018473A KR 890018473 A KR890018473 A KR 890018473A KR 910011245 A KR910011245 A KR 910011245A
Authority
KR
South Korea
Prior art keywords
layer
formulation
acrylic resin
active substance
nausea
Prior art date
Application number
KR1019890018473A
Other languages
Korean (ko)
Inventor
조정식
윤용상
Original Assignee
안시환
제일제당 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 안시환, 제일제당 주식회사 filed Critical 안시환
Priority to KR1019890018473A priority Critical patent/KR910011245A/en
Publication of KR910011245A publication Critical patent/KR910011245A/en

Links

Abstract

내용 없음No content

Description

멀미, 오심 및 구토 예방용 스코폴라민 경피 흡수팻취제Scopolamine transdermal absorption patch for preventing motion sickness, nausea and vomiting

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

제1도는 본 발명에 따라 제조될 수 있는 바람직한 경피흡수 팻취제의 외형도중의 하나이며,1 is one of the outlines of preferred transdermal absorption patches that can be prepared according to the present invention,

제2도는 제1도의 단면도이다.2 is a cross-sectional view of FIG.

Claims (8)

첫번째층은 면에 접한 방출층이고, 두번째층은 압력감수성 부착재로 저분자량의 아크릴수지 약20-75% 압력감수성 부착제로 고분자량의 아크릴수지 약15-80%, 활성물질의 운반체 1.0-15%와 활성물질 0.5-8%로 구성된 단일 또는 다층의 기질층이며 세번째층은 지지층으로 구성된 경피성 팻취 제제.The first layer is a surface-releasing layer, the second layer is a pressure sensitive adhesive, about 20-75% of a low molecular weight acrylic resin, a pressure sensitive adhesive, about 15-80% of a high molecular weight acrylic resin, and a carrier of active material 1.0-15. A transdermal patch preparation consisting of a single or multi-layered substrate layer consisting of% and 0.5-8% active substance, the third layer comprising a support layer. 제1항에 있어서, 활성물질이 스코폴라민인 제제.The formulation according to claim 1, wherein the active substance is scopolamine. 제1항에 있어서, 아크릴수지는 비닐아세테이트 아크릴레이트 멀티폴리머 또는 기타 아크릴레이트 폴리머인 제제.The formulation of claim 1 wherein the acrylic resin is a vinyl acetate acrylate multipolymer or other acrylate polymer. 제1항에 있어서, 활성물질의 매개체는 폴리에틸렌글리콜200,300,400 또는 폴리에틸렌글리콜과 프로필렌글리콜 혼합물, 식물유, 이소푸로필팔미테이트, 이소푸로필미리스테이트와의 조합물 중에서 선택한 제제.The agent according to claim 1, wherein the medium of the active substance is selected from polyethylene glycol 200, 300, 400 or a combination of polyethylene glycol and propylene glycol mixture, vegetable oil, isofurophyl palmitate, isofurofilmyristate. 제1항에 있어서, 방출층이 실리 콘피막 방출물질인 제제.The formulation of claim 1, wherein the release layer is a silicon film release material. 제1항에 있어서, 지지층이 알루미늄화된 물질인 제제.The formulation of claim 1, wherein the support layer is an aluminized material. 제1항에 있어서, 기질면의 표면적인 약 1.2-6.0㎠인 제제.The formulation of claim 1, wherein the surface area of the substrate surface is about 1.2-6.0 cm 2. 제1항에 있어서, 기질의 두께가 0.05-0.5밀리미터인 다층 혹은 다층으로 이루어진 제제.The formulation of claim 1, wherein the substrate has a thickness of 0.05-0.5 millimeters or multilayers. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019890018473A 1989-12-13 1989-12-13 Scopolamine transdermal absorption patch for preventing motion sickness, nausea and vomiting KR910011245A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890018473A KR910011245A (en) 1989-12-13 1989-12-13 Scopolamine transdermal absorption patch for preventing motion sickness, nausea and vomiting

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019890018473A KR910011245A (en) 1989-12-13 1989-12-13 Scopolamine transdermal absorption patch for preventing motion sickness, nausea and vomiting

Publications (1)

Publication Number Publication Date
KR910011245A true KR910011245A (en) 1991-08-07

Family

ID=67662201

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890018473A KR910011245A (en) 1989-12-13 1989-12-13 Scopolamine transdermal absorption patch for preventing motion sickness, nausea and vomiting

Country Status (1)

Country Link
KR (1) KR910011245A (en)

Similar Documents

Publication Publication Date Title
JP3011459B2 (en) Device for transdermal drug delivery with controlled time variation in skin permeation
KR900700064A (en) Laminated Hybrids for Transdermal Administration of Fentanyl
JP5308149B2 (en) Non-fiber transdermal therapeutic system and manufacturing method thereof
KR920702619A (en) Patch
CA2045290A1 (en) Plaster with a high content of softening ingredients
AU2961802A (en) Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system
KR910000063A (en) Multi-Layer Directional Emitter
CA2000401A1 (en) Percutaneous Pharmaceutical Preparation
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
CA2115570A1 (en) Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
KR950031058A (en) Percutaneous Absorption Formulation
SK284622B6 (en) Pharmaceutical composition comprising anti-oxidant and use of antioxidant to stabilise this composition
KR900016413A (en) Fixing tape
ATE182269T1 (en) SOLVENT-FREE ACTIVE PLASTER CONTAINING VOLATILE INGREDIENTS
WO2002034200A3 (en) Transdermal therapeutic systems comprising photosensitive active substances
KR880009071A (en) Deodorant and Deodorant Resin Site
KR850700218A (en) Pharmaceutical composition
ATE280574T1 (en) PLASTER CONTAINING ISOSORBIDE DINITRATE
CA2339836A1 (en) Active ingredient support in the form of a film
ES2253257T3 (en) TRANSDERMAL ADMINISTRATION SYSTEM FOR THE TRANSFER OF ACETILSALICILIC ACID AND / OR SALICILIC ACID.
KR900011458A (en) Superficial treatment system containing 5-fluorouracil, an antineoplastic active substance
SK149797A3 (en) Transdermal therapeutic system (tts) for administering testosterone
KR910011245A (en) Scopolamine transdermal absorption patch for preventing motion sickness, nausea and vomiting
JP2004121828A (en) Skin patch drug and its base material sheet
PT1011674E (en) TRANSDERMIC THERAPEUTIC SYSTEM WITH THE ACTIVE SUBSTANCE SCOPOLAMINE BASE

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application